Relationship between potential opioid-related adverse effects and hospital length of stay in patients receiving opioids after orthopedic surgery

Pharmacotherapy

Volumn 32, Issue 6, 2012, Pages 502-514

  Pizz, Laura T ^a   Toner, Richard ^a   Foley, Kathleen ^a   Thomson, Erin ^a   Chow, Wing ^c   Kim, Myoung ^c   Couto, Joseph ^a   Royo, Marc ^a   Viscusi, Eugene ^b  

^a JEFFERSON COLLEGE OF POPULATION HEALTH   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c JANSSEN RESEARCH AND DEVELOPMENT   (United States)

Author keywords

Adverse effects; Health care utilization; Length of stay; Opioid; Orthopedic; Postoperative care

Indexed keywords

MORPHINE; NARCOTIC ANALGESIC AGENT;

ADULT; ADVERSE OUTCOME; CONFUSION; CONSTIPATION; DISEASE ASSOCIATION; DIZZINESS; DRUG EFFECT; DRUG SAFETY; DRUG USE; FEMALE; HIP SURGERY; HOSPITALIZATION; HUMAN; HYPOXIA; KNEE SURGERY; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; NAUSEA; OPIOID INDUCED EMESIS; ORTHOPEDIC SURGERY; PATIENT ASSESSMENT; POSTOPERATIVE PERIOD; PREDICTION; PRURITUS; RESPIRATION DEPRESSION; RETROSPECTIVE STUDY; REVIEW; SHOULDER SURGERY; SPINE SURGERY; URINE RETENTION;

ACADEMIC MEDICAL CENTERS; ANALGESICS, OPIOID; FEMALE; HUMANS; LENGTH OF STAY; LINEAR MODELS; MALE; MEDICAL RECORDS; MIDDLE AGED; ORTHOPEDIC PROCEDURES; PAIN, POSTOPERATIVE; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES;

EID: 84864602546     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1875-9114.2012.01101.x     Document Type: Review

References (46)

1. Blumenthal S, Min K, Marquardt M, Borgeat A. Postoperative intravenous morphine consumption, pain scores, and side effects with perioperative oral controlled-release oxycodone after lumbar discectomy. Anesth Analg 2007;105:233-7
2. American Society of Anesthesiologists Task Force on Acute Pain Management. Practice guidelines for acute pain management in the perioperative setting: An updated report by the American Society of Anesthesiologists Task Force on Acute Pain Management. Anesthesiology 2004;100:1573-81
3. Rosenquist RW, Rosenberg J. Postoperative pain guidelines. Reg Anesth Pain Med 2003;28:279-88
4. Gordon DB, Dahl JL, Miaskowski C, et al. American Pain Society recommendations for improving the quality of acute and cancer pain management: American Pain Society Quality of Care Task Force. Arch Intern Med 2005;165:1574-80
5. Agency for Health Care Policy and Research. Acute pain management: Operative or medical procedures and trauma. Clinical Practice Guideline No.1. AHCPR Pub. No. 92-0032. Rockville, MD: AHCPR, 1992
6. Wheeler M, Oderda GM, Ashburn MA, Lipman AG. Adverse events associated with postoperative opioid analgesia: A systematic review. J Pain 2002;3:159-80
7. Hong D, Flood P, Diaz G. The side effects of morphine and hydromorphone patient-controlled analgesia. Anesth Analg 2008;107:1384-9
8. Oderda GM, Said Q, Evans RS, et al. Opioid-related adverse drug events in surgical hospitalizations: Impact on costs and length of stay. Ann Pharmacother 2007;41:400-6
9. Hutchison RW, Chon EH, Tucker WF, et al. A comparison of a fentanyl, morphine, and hydromorphone patient-controlled intravenous delivery for acute postoperative analgesia: A multicenter study of opioid-induced adverse reactions. Hosp Pharm 2006;41:659-63
10. Philip BK, Reese PR, Burch SP. The economic impact of opioids on postoperative pain management. J Clin Anesth 2002;14:354-64
11. Illgen RL, Pellino TA, Gordon DB, Butts S, Heiner JP. Prospective analysis of a novel long-acting oral opioid analgesic regimen for pain control after total hip and knee arthroplasty. J Arthroplasty 2006;21:814-20
12. Minkowitz HS, Rathmell JP, Vallow S, Gargiulo K, Damaraju CV, Hewitt DJ. Efficacy and safety of the fentanyl iontophoretic transdermal system (ITS) and intravenous patient-controlled analgesia (IV PCA) with morphine for pain management following abdominal or pelvic surgery. Pain Med 2007;8:657-68
13. Viscusi ER. Patient-controlled drug delivery for acute postoperative pain management: A review of current and emerging technologies. Reg Anesth Pain Med 2008;33:146-58
14. Rathmell JP, Wu CL, Sinatra RS, et al. Acute post-surgical pain management: A critical appraisal of current practice. Reg Anesth Pain Med 2006;31:1-42
15. Kehlet H. Postoperative opioid sparing to hasten recovery: What are the issues? Anesthesiology 2005;102:1083-5
16. Hill RP, Lubarsky DA, Phillips-Bute B, et al. Cost-effectiveness of prophylactic antiemetic therapy with ondansetron, droperidol, or placebo. Anesthesiology 2000;92:958-67
17. Watcha MF, Smith I. Cost-effectiveness analysis of antiemetic therapy for ambulatory surgery. J Clin Anesth 1994;6:370-7
18. Tang J, Watcha MF, White PF. A comparison of costs and efficacy of ondansetron and droperidol as prophylactic antiemetic therapy for elective outpatient gynecologic procedures. Anesth Analg 1996;83:304-13
19. White PF, Watcha MF. Postoperative nausea and vomiting: Prophylaxis versus treatment. Anesth Analg 1999;89:1337-9
20. Kovac AL. Prevention and treatment of postoperative nausea and vomiting. Drugs 2000;59:213-43
21. Bates JJ, Foss JF, Murphy DB. Are peripheral opioid antagonists the solution to opioid side effects? Anesth Analg 2004;98:116-22
22. Berde C, Nurko S. Opioid side effects-mechanism-based therapy. N Engl J Med 2008;358:2400-2
23. Thomas J, Karver S, Cooney GA, et al. Methylnaltrexone for opioid-induced constipation in advanced illness. N Engl J Med 2008;358:2332-43
24. Slatkin N, Thomas J, Lipman AG, et al. Methylnaltrexone for treatment of opioid-induced constipation in advanced illness patients. J Support Oncol 2009;7:39-46
25. Rosow CE, Gomery P, Chen TY, Stefanovich P, Stambler N, Israel R. Reversal of opioid-induced bladder dysfunction by intravenous naloxone and methylnaltrexone. Clin Pharmacol Ther 2007;82:48-53
26. Shaiova L, Rim F, Friedman D, Jahdi M. A review of methylnaltrexone, a peripheral opioid receptor antagonist, and its role in opioid-induced constipation. Palliat Support Care 2007;5:161-6
27. Viscusi ER, Goldstein S, Witkowski T, et al. Alvimopan, a peripherally acting mu-opioid receptor antagonist, compared with placebo in postoperative ileus after major abdominal surgery: Results of a randomized, double-blind, controlled study. Surg Endosc 2006;20:64-70
28. Oderda GM, Evans RS, Lloyd J, et al. Cost of opioid-related adverse drug events in surgical patients. J Pain Symptom Manage 2003;25:276-83
29. Reinberg S. Joint replacement soars as number of docs fall. US News & World Report. Available from http://health.usnews.com/health-news/family- health/pain/articles/2009/02/26/joint-replacement-soars-as-number-of-docs-falls. Accessed October 25, 2011
30. Fehring TK, Iorio R, Odum S. Joint Replacement Access in 2016: A Supply Side Crisis. Poster Presentation Number: P043. American Academy of Orthopedic Surgeons, 2009 Annual Meeting Poster Presentations, 2009
31. Cowan JA Jr, Chandler WF. Changing trends in the use and costs of procedures performed by neurosurgeons in the United States. Clin Neurosurg 2007;54:209-11
32. Correll DJ, Viscusi ER, Grunwald Z, Moore JH Jr. Epidural analgesia compared with intravenous morphine patient-controlled analgesia: Postoperative outcome measures after mastectomy with immediate TRAM flap breast reconstruction. Reg Anesth Pain Med 2001;26:444-9
33. Brunton L, Lazo J, Parker K. Goodman and Gilman's the pharmacologic basis of therapeutics. New York, NY: McGraw-Hill Companies, 2006
34. Krames ES. Intraspinal opioid therapy for chronic nonmalignant pain: Current practice and clinical guidelines. J Pain Symptom Manage 1996;11:333-52
35. Sylvester RK, Lindsay SM, Schauer C. The conversion challenge: From intrathecal to oral morphine. Am J Hosp Palliat Care 2004;21:143-7
36. Gan TJ, Sinha AC, Kovac AL, et al. A randomized, doubleblind, multicenter trial comparing transdermal scopolamine plus ondansetron to ondansetron alone for the prevention of postoperative nausea and vomiting in the outpatient setting. Anesth Analg 2009;108:1498-504
37. Kovac AL, Pearman MH, Khalil SN, et al. Ondansetron prevents postoperative emesis in male outpatients. S3A-379 Study Group. J Clin Anesth 1996;8:644-51
38. Fortney JT, Gan TJ, Graczyk S, et al. A comparison of the efficacy, safety, and patient satisfaction of ondansetron versus droperidol as antiemetics for elective outpatient surgical procedures. S3A-409 and S3A-410 Study Groups. Anesth Analg 1998;86:731-8
39. Skledar SJ, Williams BA, Vallejo MC, et al. Eliminating postoperative nausea and vomiting in outpatient surgery with multimodal strategies including low doses of nonsedating, offpatent antiemetics: Is "zero tolerance" achievable? Scientific-WorldJournal 2007;7:959-77
40. Birmingham SD, Mecklenburg BW, Lujan E, Dacanay RG, Boyle PK, Green R. Dolasetron versus ondansetron as singleagent prophylaxis for patients at increased risk for postoperative nausea and vomiting: A prospective, double-blind, randomized trial. Mil Med 2006;171:913-6
41. Michaloliakou C, Chung F, Sharma S. Preoperative multimodal analgesia facilitates recovery after ambulatory laparoscopic cholecystectomy. Anesth Analg 1996;82:44-51
42. Ramirez-Ruiz M, Smith I, White PF. Use of analgesics during propofol sedation: A comparison of ketorolac, dezocine, and fentanyl. J Clin Anesth 1995;7:481-5
43. Sukhani R, Vazquez J, Pappas AL, Frey K, Aasen M, Slogoff S. Recovery after propofol with and without intraoperative fentanyl in patients undergoing ambulatory gynecologic laparoscopy. Anesth Analg 1996;83:975-81
44. Stahlgren LR, Trierweiler M, Tommeraasen M, et al. Comparison of ketorolac and meperidine in patients with postoperative pain-impact on health care utilization. Clin Ther 1993;15:571-80
45. Roberts GW, Bekker TB, Carlsen HH, Moffatt CH, Slattery PJ, McClure AF. Postoperative nausea and vomiting are strongly influenced by postoperative opioid use in a doserelated manner. Anesth Analg 2005;101:1343-8
46. Zhao SZ, Chung F, Hanna DB, Raymundo AL, Cheung RY, Chen C. Dose-response relationship between opioid use and adverse effects after ambulatory surgery. J Pain Symptom Manage 2004;28:35-46.